CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.

"all data are available in the main text or additional file 1"

"Declarations Ethics approval and consent to participateOur study was approved by the Ethics Committee on Scientific Research of Shandong University, Qilu Hospital, and informed consent was obtained from all the patients participating in the study. Consent for publicationAll authors agree with the content of the manuscript and agree to this submission. Competing interestsAll the authors declare they have no competing interests. Competing interests All the authors declare they have no competing interests."

"Funding This work was supported by National Key Research and Development Program (No. 2020YFA0712400), Special Foundation for Taishan Scholars (No. ts20190971), National Natural Science Foundation of China ( No. 81874119; No. 82072912; No. 82004122), China Postdoctoral Science Foundation (No. 2020M682199), Shandong Provincial Natural Science Foundation, China (No. ZR2020QH335, No. ZR2019LZL003), Chen Xiao-ping Foundation for the Development of Science and Technology of Hubei Province (CXPJJH121001-2021003), 2021 Shandong Medical Association Clinical Research Fund—Qilu Special Project (YXH2022ZX02160), Foundation from Clinical Research Center of Shandong University (No. 2020SDUCRCA015), Qilu Hospital Clinical New Technology Developing Foundation (No. 2019-3)."